Innovation
177 patent families (75 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 11,748 times.
| Year | Filings |
|---|---|
| 2015 | 27 |
| 2016 | 32 |
| 2017 | 39 |
| 2018 | 45 |
| 2019 | 51 |
| 2020 | 49 |
| 2021 | 44 |
| 2022 | 27 |
| 2023 | 26 |
| 2024 | 17 |
| 2025 | 16 |
| 2026 | 3 |
Social engagement
Social engagement: 85.5K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
19 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 32% |
| Private equity | 4 | 21% |
| Other / undisclosed | 9 | 47% |
Recent activity
6 May 2026
Event
Galapagos Conference Call and Webcast Presentation
31 Mar 2026
Partnership
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
5 Mar 2026
Leadership hire
Chief Human Resources Officer